Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Feb 10, 2011

Premium

Response Genetics said this week that it has named Christine Meda as president of the company.

Kathleen Danenberg, who held the position previously, will continue to serve as CEO of the company.

Meda was most recently president and CEO of Arcxis Biotechnologies. She also founded and is president of RxDxLink; and has served as president and COO of Diamics. Prior to that, Meda held various positions at Roche Molecular Diagnostics, including vice president of business development and vice president of women's health.


BioNanomatrix has appointed Erik Holmlin as CEO, president, and director, succeeding Edward Erickson, who is now CEO at Saladax Biomedical.

Prior to joining BioNanomatrix, Holmlin served as CEO and president of GenVault, which merged with IntegenX last month. Prior to that he was chief commercial officer at Exiqon, where he was responsible for global sales, marketing, and clinical affairs for oncology services. In 2001, he founded molecular diagnostics company GeneOhm Sciences, which was acquired by Becton Dickinson in 2006.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.